AstraZeneca boosts respiratory unit with Actavis deal

03-03-2015

AstraZeneca boosts respiratory unit with Actavis deal

Morphart Creation / Shutterstock.com

AstraZeneca has closed a deal that will see it acquire the rights to Actavis’s branded respiratory drugs business in the US and Canada, it was announced today (March 3).


AstraZeneca, Actavis, respiratory, M&A, Tudorza

LSIPR